(S)-1-(5-FLUOROPYRIDIN-2-YL)ETHANAMINE HCL, 95.0%, 250mg

2-Methyl-6-phenylnicotinic acid, 95%, 5g

4-(3-CHLOROBENZOYL) PIPERIDINE HCL, 97.0%, 250mg

p-Xylene, min. 99%, for synthesis, 500 ml, glass packaging

2,4-Diamino-6-methoxypyrimidine, 95.0%, 25g

(S)-4-(3-bromophenyl)-6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinoline (2S,3S)-2,3-bis(benzoyloxy)succinate, 98%, 250mg

1-(2-FLUOROBENZYL)-3-IODO-1H-PYRAZOLO[3,4-B]PYRIDINE, 95.0%, 5g

Tri-p-tolylphosphine, 98.0%, 10g

Tris(2-ethylhexyl) 4,4',4''-((1,3,5-triazine-2,4,6-triyl)tris(azanediyl))tribenzoate, 97.0%, 10g

methyl 5-formylpyridine-3-carboxylate, 95.0%, 500mg

5-BROMO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-AMINE HCL, 95.0%, 250mg

TERT-BUTYL 3-ACETAMIDOAZETIDINE-1-CARBOXYLATE, 95.0%, 25g

2-METHYLIMIDAZO[1,2-A]PYRIDINE-7-CARBOXYLIC ACID, 95.0%, 250mg